{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:15:09Z","timestamp":1780082109299,"version":"3.54.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T00:00:00Z","timestamp":1533168000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Pfizer Norway"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1659-z","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T07:25:57Z","timestamp":1533194757000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Ten years of follow-up data in psoriatic arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway"],"prefix":"10.1186","volume":"20","author":[{"given":"Glenn","family":"Haugeberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Michelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stig","family":"Tengesdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger Johanne Widding","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Diamantopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Kavanaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,2]]},"reference":[{"key":"1659_CR1","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/BOR.0000000000000284","volume":"28","author":"JS Smolen","year":"2016","unstructured":"Smolen JS. Treat-to-target as an approach in inflammatory arthritis. Curr Opin Rheumatol. 2016;28:297\u2013302.","journal-title":"Curr Opin Rheumatol"},{"key":"1659_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.2009.123919","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69:631\u20137.","journal-title":"Ann Rheum Dis"},{"key":"1659_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","volume":"75","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2016;75:3\u201315.","journal-title":"Ann Rheum Dis"},{"key":"1659_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/annrheumdis-2013-203419","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Braun J, Dougados M, Emery P, Fitzgerald O, Helliwell P, et al. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis. 2014;73:6\u201316.","journal-title":"Ann Rheum Dis"},{"key":"1659_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2017-211734","volume":"77","author":"JS Smolen","year":"2018","unstructured":"Smolen JS, Schols M, Braun J, Dougados M, FitzGerald O, Gladman DD, et al. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann Rheum Dis. 2018;77:3\u201317.","journal-title":"Ann Rheum Dis"},{"key":"1659_CR6","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1136\/annrheumdis-2015-208466","volume":"75","author":"S Ramiro","year":"2016","unstructured":"Ramiro S, Smolen JS, Landewe R, van der Heijde D, Dougados M, Emery P, et al. Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis. Ann Rheum Dis. 2016;75:490\u20138.","journal-title":"Ann Rheum Dis"},{"key":"1659_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13075-015-0716-0","volume":"17","author":"G Haugeberg","year":"2015","unstructured":"Haugeberg G, Hansen IJ, Soldal DM, Sokka T. Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway. Arthritis Res Ther. 2015;17:219.","journal-title":"Arthritis Res Ther"},{"key":"1659_CR8","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/art.1780261107","volume":"26","author":"T Pincus","year":"1983","unstructured":"Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford health assessment questionnaire. Arthritis Rheum. 1983;26:1346\u201353.","journal-title":"Arthritis Rheum"},{"key":"1659_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44\u20138.","journal-title":"Arthritis Rheum"},{"key":"1659_CR10","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.berh.2007.02.004","volume":"21","author":"D Aletaha","year":"2007","unstructured":"Aletaha D, Smolen JS. The simplified disease activity index (SDAI) and clinical disease activity index (CDAI) to monitor patients in standard clinical care. Best Pract Res Clin Rheumatol. 2007;21:663\u201375.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1659_CR11","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1136\/ard.2009.122259","volume":"69","author":"M Schoels","year":"2010","unstructured":"Schoels M, Aletaha D, Funovits J, Kavanaugh A, Baker D, Smolen JS. Application of the DAREA\/DAPSA score for assessment of disease activity in psoriatic arthritis. Ann Rheum Dis. 2010;69:1441\u20137.","journal-title":"Ann Rheum Dis"},{"key":"1659_CR12","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1002\/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO;2-K","volume":"41","author":"AM van Gestel","year":"1998","unstructured":"van Gestel AM, Haagsma CJ, van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum. 1998;41:1845\u201350.","journal-title":"Arthritis Rheum"},{"key":"1659_CR13","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1136\/annrheumdis-2015-207507","volume":"75","author":"MM Schoels","year":"2016","unstructured":"Schoels MM, Aletaha D, Alasti F, Smolen JS. Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score. Ann Rheum Dis. 2016;75:811\u20138.","journal-title":"Ann Rheum Dis"},{"key":"1659_CR14","doi-asserted-by":"publisher","first-page":"528105","DOI":"10.1155\/2014\/528105","volume":"2014","author":"F Salaffi","year":"2014","unstructured":"Salaffi F, Ciapetti A, Carotti M, Gasparini S, Gutierrez M. Disease activity in psoriatic arthritis: comparison of the discriminative capacity and construct validity of six composite indices in a real world. Biomed Res Int. 2014;2014:528105.","journal-title":"Biomed Res Int"},{"key":"1659_CR15","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/art.30129","volume":"63","author":"DT Felson","year":"2011","unstructured":"Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, et al. American College of Rheumatology\/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum. 2011;63:573\u201386.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"1659_CR16","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665\u201373.","journal-title":"Arthritis Rheum"},{"key":"1659_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3899\/jrheum.160973","volume":"44","author":"B Michelsen","year":"2017","unstructured":"Michelsen B, Diamantopoulos AP, Hoiberg HK, Soldal DM, Kavanaugh A, Haugeberg G. Need for improvement in current treatment of psoriatic arthritis: study of an outpatient clinic population. J Rheumatol. 2017;44:431\u20136.","journal-title":"J Rheumatol"},{"key":"1659_CR18","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1056\/NEJMoa1615975","volume":"377","author":"P Mease","year":"2017","unstructured":"Mease P, Hall S, FitzGerald O, van der Heijde D, Merola JF, Avila-Zapata F, et al. Tofacitinib or adalimumab versus placebo for psoriatic arthritis. N Engl J Med. 2017;377:1537\u201350.","journal-title":"N Engl J Med"},{"key":"1659_CR19","first-page":"1918","volume":"32","author":"TM Madland","year":"2005","unstructured":"Madland TM, Apalset EM, Johannessen AE, Rossebo B, Brun JG. Prevalence, disease manifestations, and treatment of psoriatic arthritis in western Norway. J Rheumatol. 2005;32:1918\u201322.","journal-title":"J Rheumatol"},{"key":"1659_CR20","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","volume":"76","author":"JS Smolen","year":"2017","unstructured":"Smolen JS, Landewe R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017;76:960\u201377.","journal-title":"Ann Rheum Dis"},{"key":"1659_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/annrheumdis-2015-208337","volume":"75","author":"L Gossec","year":"2016","unstructured":"Gossec L, Smolen JS, Ramiro S, de Wit M, Cutolo M, Dougados M, et al. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis. 2016;75:499\u2013510.","journal-title":"Ann Rheum Dis"},{"key":"1659_CR22","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1136\/annrheumdis-2012-202220","volume":"72","author":"S Garces","year":"2013","unstructured":"Garces S, Demengeot J, Benito-Garcia E. The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis. Ann Rheum Dis. 2013;72:1947\u201355.","journal-title":"Ann Rheum Dis"},{"issue":"5 Suppl 93","key":"1659_CR23","first-page":"S48","volume":"33","author":"JS Smolen","year":"2015","unstructured":"Smolen JS, Schoels M, Aletaha D. Disease activity and response assessment in psoriatic arthritis using the disease activity index for psoriatic arthritis (DAPSA). A brief review. Clin Exp Rheumatol. 2015;33(5 Suppl 93):S48\u201350.","journal-title":"Clin Exp Rheumatol"},{"key":"1659_CR24","doi-asserted-by":"publisher","unstructured":"Mease PJ, Coates LC. Considerations for the definition of remission criteria in psoriatic arthritis. Seminar Arthritis Rheum. 2018 Epub ahead; \n                    https:\/\/doi.org\/10.1016\/j.semarthrit.2017.10.021\n                    \n                  .","DOI":"10.1016\/j.semarthrit.2017.10.021"},{"key":"1659_CR25","doi-asserted-by":"publisher","first-page":"e0123582","DOI":"10.1371\/journal.pone.0123582","volume":"10","author":"B Michelsen","year":"2015","unstructured":"Michelsen B, Fiane R, Diamantopoulos AP, Soldal DM, Hansen IJ, Sokka T, et al. A comparison of disease burden in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis. PLoS One. 2015;10:e0123582.","journal-title":"PLoS One"},{"key":"1659_CR26","doi-asserted-by":"publisher","first-page":"e000221","DOI":"10.1136\/rmdopen-2015-000221","volume":"2","author":"E Gvozdenovic","year":"2016","unstructured":"Gvozdenovic E, Allaart CF, van der Heijde D, Ferraccioli G, Smolen JS, Huizinga TW, et al. When rheumatologists report that they agree with a guideline, does this mean that they practise the guideline in clinical practice? Results of the international recommendation implementation study (IRIS). RMD open. 2016;2:e000221.","journal-title":"RMD open"},{"key":"1659_CR27","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/acr.23546","volume":"70","author":"BJ Smith","year":"2018","unstructured":"Smith BJ, Bolster MB, Slusher B, Stamatos C, Scott JR, Benham H, et al. Core curriculum to facilitate the expansion of a rheumatology practice to include nurse practitioners and physician assistants. Arthritis Care Res. 2018;70:672\u20138.","journal-title":"Arthritis Care Res"},{"key":"1659_CR28","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1002\/art.40111","volume":"69","author":"DH Solomon","year":"2017","unstructured":"Solomon DH, Losina E, Lu B, Zak A, Corrigan C, Lee SB, et al. Implementation of treat-to-target in rheumatoid arthritis through a learning collaborative: results of a randomized controlled trial. Arthritis Rheumatol. 2017;69:1374\u201380.","journal-title":"Arthritis Rheumatol"},{"key":"1659_CR29","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/1523-1747.ep12384205","volume":"102","author":"AB Fleischer Jr","year":"1994","unstructured":"Fleischer AB Jr, Rapp SR, Reboussin DM, Vanarthos JC, Feldman SR. Patient measurement of psoriasis disease severity with a structured instrument. J Invest Dermatol. 1994;102:967\u20139.","journal-title":"J Invest Dermatol"},{"key":"1659_CR30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/1523-1747.ep12329912","volume":"106","author":"SR Feldman","year":"1996","unstructured":"Feldman SR, Fleischer AB Jr, Reboussin DM, Rapp SR, Exum ML, Clark AR, et al. The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol. 1996;106:183\u20136.","journal-title":"J Invest Dermatol."},{"key":"1659_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/rheumatology\/keq309","volume":"50","author":"ML Hetland","year":"2011","unstructured":"Hetland ML. DANBIO\u2014powerful research database and electronic patient record. Rheumatology. 2011;50:69\u201377.","journal-title":"Rheumatology"},{"issue":"6 Suppl 47","key":"1659_CR32","first-page":"86","volume":"25","author":"T Sokka","year":"2007","unstructured":"Sokka T, Haugeberg G, Pincus T. Assessment of quality of rheumatoid arthritis care requires joint count and\/or patient questionnaire data not found in a usual medical record: examples from studies of premature mortality, changes in clinical status between 1985 and 2000, and a QUEST-RA global perspective. Clin Exp Rheumatol. 2007;25(6 Suppl 47):86\u201397.","journal-title":"Clin Exp Rheumatol"},{"key":"1659_CR33","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/art.37939","volume":"65","author":"LC Coates","year":"2013","unstructured":"Coates LC, FitzGerald O, Gladman DD, McHugh N, Mease P, Strand V, et al. Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active disease. Arthritis Rheum. 2013;65:1504\u20139.","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1659-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1659-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1659-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T19:22:56Z","timestamp":1564687376000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1659-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,2]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1659"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1659-z","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,2]]},"assertion":[{"value":"22 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The approval for this study was given by the regional ethical committee (Regional etisk komite Midt-Norge 2010\/3078). No consent from patients was needed according to the ethical committee, as all the data described above were collected as part of clinical care to facilitate treatment decisions.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GH is a founder and shareholder for DiaGraphIT AS, manufacturing the GoTreatIT\u00ae Rheuma software. The remaining authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"160"}}